1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
5
Swedbank Robur Healthcare A
Fee
1.30%
ISIN
SE0000639445
Holdings
25
We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Swedbank Robur Healthcare, we have 27 holdings where UnitedHealth is the largest holding (8.49), followed by Eli Lilly (8.12) and AstraZeneca (6.21).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Swedbank Robur Healthcare.
| UBS Lux Equity Fund Biotech USD | Swedbank Robur Healthcare |
|---|---|
|
10.04 % |
 8.49 % |
|
9.21 % |
8.12 % |
|
4.66 % |
  6.21 % |
|
4.13 % |
 5.78 % |
|
3.75 % |
5.01 % |
| - |
 4.71 % |
| - |
4.45 % |
| - |
4.27 % |
| - |
4.24 % |
| - |
4.03 % |
| - |
 3.84 % |
| - |
3.73 % |
| - |
3.56 % |
| - |
3.28 % |
| - |
 2.96 % |
| - |
2.76 % |
| - |
2.19 % |
| - |
1.78 % |
| - |
1.62 % |
| - |
 1.55 % |
| - |
1.43 % |
| - |
1.36 % |
| - |
1.36 % |
| - |
0.91 % |
| - |
0.83 % |
The list of fund holdings was last updated on September 10, 2025.
